Patterns of EMG-EMG coherence in limb dystonia

Mov Disord. 2004 Jul;19(7):758-769. doi: 10.1002/mds.20075.

Abstract

Dystonia of the limbs may be due to a wide range of aetiologies and may cause major functional limitation. We investigated whether the previously described pathological 4 to 7 Hz drive to muscles in cervical dystonia is present in patients with aetiologically different types of dystonia of the upper and lower limbs. To this end, we studied 12 symptomatic and 4 asymptomatic carriers of the DYT1 gene, 6 patients with symptomatic dystonia due to focal basal ganglia lesions, and 11 patients with fixed dystonia, a condition assumed to be mostly psychogenic in aetiology. We evaluated EMG-EMG coherence in the tibialis anterior (TA) of these and 15 healthy control subjects. Ten of 12 (83%) of symptomatic DYT1 patients had an excessive 4 to 7 Hz common drive to TA, evident as an inflated coherence in this band. This drive also involved the gastrocnemius, leading to co-contracting electromyographic bursts. In contrast, asymptomatic DYT1 carriers, patients with symptomatic dystonia, patients with fixed dystonia, and healthy subjects showed no evidence of such a drive or any other distinguishing electrophysiological feature. Moreover, the pathological 4 to 7 Hz drive in symptomatic DYT1 patients was much less common in the upper limb, where it was only present in 2 of 6 (33%) patients with clinical involvement of the arms. We conclude that the nature of the abnormal drive to dystonic muscles may vary according to the muscles under consideration and, particularly, with aetiology.

MeSH terms

  • Adult
  • Anterior Compartment Syndrome / complications
  • Anterior Compartment Syndrome / physiopathology
  • Anti-Dyskinesia Agents / therapeutic use
  • Anticonvulsants / therapeutic use
  • Antiparkinson Agents / therapeutic use
  • Basal Ganglia Diseases / complications
  • Basal Ganglia Diseases / pathology
  • Basal Ganglia Diseases / physiopathology
  • Botulinum Toxins / therapeutic use
  • Clonazepam / therapeutic use
  • Dystonia / drug therapy
  • Dystonia / etiology
  • Dystonia / physiopathology*
  • Electromyography / instrumentation
  • Electromyography / statistics & numerical data
  • Female
  • Humans
  • Male
  • Middle Aged
  • Molecular Chaperones / genetics
  • Trihexyphenidyl / therapeutic use

Substances

  • Anti-Dyskinesia Agents
  • Anticonvulsants
  • Antiparkinson Agents
  • Molecular Chaperones
  • TOR1A protein, human
  • Clonazepam
  • Trihexyphenidyl
  • Botulinum Toxins